ad

Mahindra Manulife Multi Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?

15 Sept 20263:19 pm

Mahindra Manulife Multi Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?

Mahindra Manulife Multi Cap Fund Direct Growth Plan currently has a NAV of ₹46.8972 as of 11 September 2026 and a scheme AUM of ₹7,662 Cr. Its 1-year, 3-year and 5-year returns are 14.57%, 16.86% and 16.64%, and the fund sits in the High Risk category.

Our view is that this is a multi-cap equity option for investors who can tolerate sharp swings and still stay invested long enough for compounding to matter. The return pattern is stronger over 3 years and 5 years than over 1 year, which tells us the fund has rewarded patience better than short holding periods.

Quick facts

Particular Details
NAV ₹46.8972 as of 11 Sep 2026
AUM ₹7,662 Cr
Expense Ratio 0.4%
Launch Date 11 May 2017
Min SIP ₹500
Risk Category High Risk
Benchmark Nifty 50
Fund Category Equity
Exit Load 1% on or before 3M, Nil after 3M
Fund Managers Vishal Jajoo, Neelesh Dhamnaskar

The fund is managed by Vishal Jajoo and Neelesh Dhamnaskar.

Source data date: as of 11 Sep 2026

Performance

Period Fund return Benchmark return
1M 0.52% -3.66%
3M 6.92% -1.91%
1Y 14.57% -7.62%
3Y 16.86% 6.22%
5Y 16.64% 5.84%

The recent picture is healthy. Over 1 month, 3 months and 1 year, the fund stayed positive while the benchmark was negative in each period. That matters because it shows relative resilience even when the broad market measure was weaker.

The longer view is even more useful. The 3-year and 5-year returns are close to each other, which suggests the fund has delivered a fairly steady compounding path rather than a one-off surge followed by a sharp fade. The 3-year figure is slightly higher than the 5-year figure, so recent multi-year gains have been somewhat stronger than the full 5-year average.

Against the benchmark, the fund is clearly ahead in every listed period. The gap is especially wide in 1 year, where the benchmark is negative while the fund remains comfortably positive. That said, the 1-month and 3-month numbers also show that this is still an equity fund with day-to-day movement, not a smooth line upward.

Our interpretation is that the fund’s short-term behaviour differs from the benchmark’s weaker stretch, while the 3-year and 5-year numbers indicate a more durable compounding profile. For investors, that combination usually matters more than one isolated month.

Source data date: as of 11 Sep 2026

Should you BUY or HOLD Mahindra Manulife Multi Cap?

A fund’s past returns alone don’t tell you whether you should buy it today or continue holding it.

The right decision depends on factors such as your current allocation, purchase price, risk profile, investment horizon and the role this fund plays in your overall portfolio.

Already holding Mahindra Manulife Multi Cap? Thinking of investing now?

Get your portfolio analysed for FREE by SEBI-registered Investment Adviser (RIA) through Univest MF Premium

Peer comparison

Fund 1Y return 3Y return 5Y return
TRUSTMF Multi Cap Fund Direct Growth Plan 19.74% Data not available Data not available
Groww Multicap Fund Direct Growth Plan 19.32% Data not available Data not available
Mahindra Manulife Multi Cap Fund Direct Growth Plan 14.57% 16.86% 16.64%
ITI Multi Cap Fund Direct Growth Plan 13.37% 16.8% 14.5%
Bank of India Multi Cap Fund Direct Growth Plan 13.11% 17.03% Data not available

This assessment is prepared by Uniapps Investment Adviser Pvt. Ltd. under SEBI Registered Investment Adviser registration INA000017639. On 1-year performance, the fund trails the stronger recent peer numbers shown here, but it is still ahead of the peer group’s lower 1-year figures. The 3-year and 5-year figures tell a different story: the fund holds up well on 3-year performance and remains competitive on 5-year performance, even though one peer shows a slightly higher 3-year return. Taken together, the short-term comparison looks less forceful than the longer-term picture.

Source data date: as of 11 Sep 2026

Portfolio: where your money goes

Holding Sector Weight
Triparty Repo Cash & Cash Equivalents and Net Assets 8.69%
Multi Commodity Exchange of India Limited Finance 4.86%
Neuland Laboratories Limited Healthcare 4%
Divi’S Laboratories Limited Healthcare 3.93%
ICICI Bank Limited Bank 3.49%
Adani Enterprises Limited Trading 3.23%
Oil India Limited Crude Oil 2.59%
Apl Apollo Tubes Limited Iron & Steel 2.51%
Torrent Pharmaceuticals Limited Healthcare 2.41%
PTC Industries Ltd Automobile & Ancillaries 2.08%

The largest disclosed holding is Triparty Repo at 8.69%, which is meaningful but not extreme for a diversified multi-cap fund. The drop from the first holding to the tenth is fairly sharp, because the tenth position is only 2.08%, so the visible book is clearly not evenly weighted.

The top 10 holdings together account for approximately 37.79% of the portfolio, and the fund has 64 disclosed holdings in total. That combination suggests the portfolio is spread across a broad set of names, while the largest positions still have enough weight to shape near-term movement. In our view, that mix may give the fund a balance of diversification and conviction, but the healthcare and finance exposures in the top holdings could still influence results more than the smaller positions.

Because the disclosed holdings continue beyond the top 10, the tail beyond these names may matter as well. Even so, the visible concentration is moderate rather than highly diffuse, which is consistent with an active multi-cap approach.

To see all holdings, visit the Mahindra Manulife Multi Cap Fund Direct Growth Plan page

Source data date: as of 11 Sep 2026

Who should invest

This fund fits investors who are comfortable with High Risk equity exposure and can stay invested through short-term swings. The 1-year return is solid, but the stronger 3-year and 5-year numbers show that patience has mattered more than tactical entry and exit.

It suits an investment horizon of at least three to five years, because that is where the return pattern looks more convincing and more consistent with an equity growth allocation. The benchmark comparison also supports a long-term lens: the fund has outpaced Nifty 50 across the listed periods.

The main trade-off is volatility. The fund has a broad portfolio and active stock selection, but investors must accept that returns can move unevenly in the short run even when the longer-term picture is stronger.

Tax and exit load

Holding period Tax rate Description
Units held less than 1 year 20% Short-term capital gains tax
Units held more than 1 year 12.5% Long-term capital gains tax

Exit load applies at 1% if units are sold within 3 months, and it is nil after 3 months.

Source data date: as of 11 Sep 2026

Frequently asked questions

What is the current NAV of Mahindra Manulife Multi Cap Fund Direct Growth Plan?
The current NAV is ₹46.8972 as of 11 September 2026.

What are the fund’s 1-year, 3-year and 5-year returns?
The returns are 14.57% over 1 year, 16.86% over 3 years and 16.64% over 5 years.

How does this fund compare with Nifty 50?
It has beaten Nifty 50 in each listed period. The benchmark is negative over 1 month, 3 months and 1 year, while the fund remains positive across those periods.

How does it compare with the peer funds listed here?
Its 1-year return is below the strongest recent peer figures shown, but its 3-year and 5-year results remain competitive and compare well with the longer-term numbers available for peers.

What is the minimum SIP amount?
The minimum SIP amount is ₹500.

Who manages the fund and what is the exit load?
The fund is managed by Vishal Jajoo and Neelesh Dhamnaskar. Exit load is 1% if units are sold within 3 months and nil after 3 months.

Bottom line

Mahindra Manulife Multi Cap Fund Direct Growth Plan looks stronger on a longer holding period than on a short one. Its return profile is better than the benchmark across the listed periods, and the peer comparison shows that its 3-year and 5-year numbers remain broadly competitive even if some peers have a stronger 1-year run. With a High Risk tag and a portfolio that blends cash-like exposure with active stock bets, it suits investors who can accept volatility in exchange for equity-style compounding.

Published on 15 September 2026 at 3:18 PM IST

RIA disclosure

Mutual fund investments are subject to market risks. Read all scheme-related documents carefully before investing. This review is prepared by Uniapps Investment Adviser Pvt. Ltd. (earlier known as Uniapps Global Research Pvt. Ltd.) under SEBI Registered Investment Adviser registration INA000017639 for general informational purposes and is not personalized investment advice.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down